Skip to Content
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 10/28/16

CIP Holds Workshop on Immune Modulation Therapy and Imaging

Immune Modulation Therapy and Imaging: What can we do in clinical trials now?

Posted on July 05, 2016

Immunotherapy is rapidly becoming a successful strategy in treating malignancies. NCI is investing a large percentage of its resources to evaluate the role of various immunotherapies — either alone or in combination with other cytotoxic or cytostatic therapies. Assessment of tumor response with anatomic imaging and with the standard RECIST criteria has not been very helpful in patients receiving immunotherapy. Therefore, the Cancer Imaging Program is actively pursuing alternative methods of tumor response assessment in this setting. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is partnering with CIP to conduct this workshop on May 2nd, 2016.

Participant List
Workshop Agenda
Powerpoint Slides from the Workshop
Link to Full Videocast of Workshop: http://videocast.nih.gov/launch.asp?19660